Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-2428-2026

Medline Industries, LP recalls Medline convenience kit: BHS NEURO DYNJ904900N MEDTRX NEURO PACK DYNJ67267B…

Medline Industries, LPNorthfield, IL, United StatesReported Jun 24, 2026 · 24 days ago
Legal News Analyst ·

Reason for recall

Kits contain recalled lot of Ferndale Laboratories MASTISOL Liquid Adhesive. Butyrate tubing may crack during actuation and render product unusable for application.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Affected products & lots

  • Medline convenience kit: BHS NEURO DYNJ904900N MEDTRX NEURO PACK DYNJ67267B MRI DBS PACK DYNJ9814630O NEURO CDS-LF CDS983383L NEURO PACK DYNJ59397Q DYNJT7315 NEURO PACK-LF DYNJ25097I NEURO VP SHUNT/VAGAL NERVE-RF DYNJ21925S PK NEURO SHUNT BUMC DYNJT6428 RR-NEURO DBS HEAD PACK-LF DYNJ0785736M VP SHUNTSYNJ10307B
    UDI-DI 10198459504273
    32 affected lots
    25LBB457DYNJ67267B1019845908433125LBQ732DYNJ9814630O1019532758729125LBD665CDS983383L
    +24 more1019845922457725LBC092DYNJ59397Q1019845949542725LMG049DYNJT73151019845962022525LBO095DYNJ25097I1019845944955025KBC747DYNJ21925S1019532710502025KBD83525LBR371DYNJT64281019845955366026AMA602DYNJ0785736M1019845948714925LMI831SYNJ10307B1019532700724925LBE309

What the firm is doing

Firm began notifying consignees on 4/27/2026. Customers were instructed to request stickers to over-label affected convenience kits with a warning label. Warning label indicates for user to remove the affected component and replace it with product from supply. No kits are to be returned.

DistributionShow details

US Nationwide distribution. OUS distribution pending.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls